The director of the University of Pittsburgh Cancer Institute is heading to Seattle to become the executive director of the Fred Hutch/University of Washington Cancer Consortium.
Or, as she described it, she’s exchanging three rivers for Puget Sound.
On Dec. 1, Nancy E. Davidson will assume duties “as a bridge builder across the cancer treatment, clinical and translational research programs” at the Seattle-based cancer center.
“I have loved Pittsburgh. It’s been a really embracing city, and I have loved the University of Pittsburgh and UPMC,” she said Monday.
“But I’ve been serving on the external advisory board for Fred Hutch for five years and watching what they are doing and watching their growth. So when I was approached with the opportunity to join the team and the opportunity to do something a little bit different — but still in the cancer field — I felt I could take what I’ve learned in Pittsburgh and apply it to a new setting.”
Arthur S. Levine, senior vice chancellor for health sciences and the dean of the University of Pittsburgh School of Medicine, said during the seven years of Dr. Davidson’s leadership, the Pitt Cancer Institute had “expanded its deep bench of scientists, added important new research grants to remain on the leading edge of cancer research, and cemented its standing as the region’s only National Cancer Institute-designated Comprehensive Cancer Center.”
“We wish Nancy well in her new role and appreciate that she is leaving UPCI in such a strong position to lead cancer research well into the future,” Dr. Levine said.
A Fred Hutch/University of Washington statement described Dr. Davidson as “a top opinion leader in the field of breast cancer biology and treatment” with many published editorials, commentaries and reviews that “provide perspective for key research papers as well as critical areas in breast cancer biology and treatment.”
Gary Gilliland, president and director of Fred Hutch, said she is an “internationally recognized expert in breast cancer” with successful leadership at the Pitt Cancer Institute, among other notable positions as a member of the National Academy of Medicine, past president of the American Society of Clinical Oncology and current president of the American Association for Cancer Research.
“She is ideally suited to further enrich the already outstanding interactions between the Seattle Cancer Care Alliance, University of Washington Medicine and Fred Hutch,” Dr. Gilliland said. “I am eagerly looking forward to working with her.”
Dr. Davidson said the Pitt Cancer Institute is working to take new therapies from research “bench to bedside,” with clinical trials underway for head and neck cancer treatments and a colon cancer vaccine, among others. She said she inherited a strong institute when she arrived at Pitt “and I hope I made it strong enough” to continue on its path of progress.
Her departure, she said, is bittersweet.
“I’m so grateful for the opportunity to work in Pittsburgh, and it’s been a tremendous honor and great pleasure to work with all my colleagues at the University of Pittsburgh and UPMC,” she said.
Dr. Davidson has a bachelor’s degree from Wellesley College and is a 1979 graduate of the Harvard Medical School. She also has held positions at Johns Hopkins University in Baltimore.
David Templeton: dtempleton@post-gazette.com or 412-263-1578.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.